Lactobacillus rhamnosus HN001 decreases the severity of necrotizing enterocolitis in neonatal mice and preterm piglets: evidence in mice for a role of TLR9.
- 2014-06-01
- Clinical Trial
- American Journal of Physiology-Gastrointestinal and Liver Physiology 306(11)
- M. Good
- C. Sodhi
- J. Ozolek
- R. Buck
- Karen C. Goehring
- Debra L Thomas
- A. Vikram
- K. Bibby
- Michael J. Morowitz
- B. Firek
- Peng Lu
- D. Hackam
- PubMed: 24742987
- DOI: 10.1152/ajpgi.00452.2013
- Low evidence
- Highly Cited
- Animal Study
- Mixed
We now show that oral administration of live or UV-inactivated Lactobacillus rhamnosus HN001 attenuates NEC severity in newborn mice and premature piglets, as manifest by reduced histology score, attenuation of mucosal cytokine response, and improved gross morphology.
- Effect
- Beneficial
- Effect size
- Large